pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Phase 2
ONO-2808
Multiple System Atrophy (Multi-System Degeneration)
Ono Pharmaceutical Co Ltd
Phase 1
ONO-2910
Diabetic Neuropathy
Ono Pharmaceutical Co Ltd
Phase 1
OP-3136
Human Epidermal Growth Factor Receptor 2 Negative Breast…
$OLMA
Olema Pharmaceuticals, Inc.
← prev
page 136 of 271
next →
Pain
89
Neurology
1
Preclinical
OPB-171775
Gastrointestinal Stromal Tumor (GIST)
$BDRX
Biodexa Pharmaceuticals Plc
Phase 2
OPC-1
Acute Spinal Cord Injury
$LCTX
Lineage Cell Therapeutics, Inc.
Phase 1
OPC-214870
Epilepsy
Otsuka Pharmaceutical Co Ltd
Phase 2
OPCT-001
Retinal Degeneration
BlueRock Therapeutics LP
OPDIVO
OPDIVO (NIVOLUMAB)
1 INDICATIONS AND USAGE OPDIVO QVANTIG is a combination o…
$BMY
BRISTOL MYERS SQUIBB CO
OPDIVO QVANTIG
OPDIVO QVANTIG (NIVOLUMAB)
1 INDICATIONS AND USAGE OPDIVO QVANTIG is a combination o…
$BMY
BRISTOL MYERS SQUIBB CO
Phase 2
OPF-310
Type 1 Diabetes (Juvenile Diabetes)
Otsuka Pharmaceutical Co Ltd
Phase 2
OPGx-BEST1
Macular Degeneration
$IRD
Opus Genetics, Inc.
Preclinical
OPGx-CNGB1
Retinitis Pigmentosa (Retinitis)
$IRD
Opus Genetics, Inc.
Phase 3
OPGx-LCA5
Leber Congenital Amaurosis (LCA)
$IRD
Opus Genetics, Inc.
Preclinical
OPGx-RDH12
Leber Congenital Amaurosis (LCA)
$IRD
Opus Genetics, Inc.
Preclinical
OPGx-RHO
Retinitis Pigmentosa (Retinitis)
$IRD
Opus Genetics, Inc.
Preclinical
OPK-88006
Metabolic Dysfunction-Associated Steatohepatitis (MASH or…
$OPK
OPKO HEALTH, INC.
Phase 1
OPL-009
Hypertension
Overseas Pharmaceuticals Ltd
Phase 3
OPL-015
Pain
Overseas Pharmaceuticals Ltd
Phase 1
OPN-6602
Refractory Multiple Myeloma
Opna Bio SA
Preclinical
OPTF-01
Glioblastoma Multiforme (GBM)
Optieum Biotechnologies Inc
OPTIONELLE
OPTIONELLE (LEVONORGESTREL TABLET, 1.5 MG)
no indication
NAARI PTE
OPTIRAY 320
OPTIRAY 320 (IOVERSOL)
no indication
LIEBEL-FLARSHEIM
OPTISON PERFLUTREN PROTEIN-TYPE A MICROSPHERES
OPTISON PERFLUTREN PROTEIN-TYPE A MICROSPHERES (HUMAN ALBUMIN MICROSPHERES AND PERFLUTREN)
no indication
GE HEALTHCARE
Preclinical
OQL-036
Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome)
OnQuality Pharmaceuticals LLC
Preclinical
OQY-8811
Multiple Myeloma (Kahler Disease)
Oqory Inc
Preclinical
OR-449
Adrenocortical Carcinoma (Adrenal Cortex Cancer)
Orphagen Pharmaceuticals Inc
Preclinical
OR-812
Male Contraception
Orphagen Pharmaceuticals Inc
Preclinical
ORG-101
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphobla…
Orgenesis Inc
ORGOVYX
ORGOVYX (RELUGOLIX)
no indication
Sumitomo Pharma America Inc
ORILISSA
ORILISSA (ELAGOLIX SODIUM)
1 INDICATIONS AND USAGE ORILISSA is indicated for the man…
$ABBV
AbbVie Inc.
